Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 2276

1.

Brain injury with diabetes mellitus: evidence, mechanisms and treatment implications.

Hamed SA.

Expert Rev Clin Pharmacol. 2017 Apr;10(4):409-428. doi: 10.1080/17512433.2017.1293521. Epub 2017 Feb 22. Review.

PMID:
28276776
2.

Metabolic endotoxemia and diabetes mellitus: A systematic review.

Gomes JM, Costa JA, Alfenas RC.

Metabolism. 2017 Mar;68:133-144. doi: 10.1016/j.metabol.2016.12.009. Epub 2016 Dec 18. Review.

PMID:
28183445
3.

Glomerular Hyperfiltration in Diabetes: Mechanisms, Clinical Significance, and Treatment.

Tonneijck L, Muskiet MH, Smits MM, van Bommel EJ, Heerspink HJ, van Raalte DH, Joles JA.

J Am Soc Nephrol. 2017 Apr;28(4):1023-1039. doi: 10.1681/ASN.2016060666. Epub 2017 Jan 31. Review.

PMID:
28143897
4.

MECHANISMS IN ENDOCRINOLOGY: Diabetes mellitus, a state of low bone turnover - a systematic review and meta-analysis.

Hygum K, Starup-Linde J, Harsløf T, Vestergaard P, Langdahl BL.

Eur J Endocrinol. 2017 Mar;176(3):R137-R157. doi: 10.1530/EJE-16-0652. Review.

5.

Cardiovascular complications of type 1 diabetes: update on the renal link.

Orchard TJ, Costacou T.

Acta Diabetol. 2017 Apr;54(4):325-334. doi: 10.1007/s00592-016-0949-7. Epub 2016 Dec 19. Review.

PMID:
27995339
6.

Association of angiotensin-converting enzyme insertion/deletion polymorphism with type 1 diabetic nephropathy: a meta-analysis.

Xu HY, Liu MM, Wang X, He XY.

Ren Fail. 2016 Oct;38(9):1320-1327. Epub 2016 Aug 8. Review.

PMID:
27498976
7.

The efficacy and safety of DPP4 inhibitors in patients with type 1 diabetes: A systematic review and meta-analysis.

Guo H, Fang C, Huang Y, Pei Y, Chen L, Hu J.

Diabetes Res Clin Pract. 2016 Nov;121:184-191. doi: 10.1016/j.diabres.2016.08.022. Epub 2016 Sep 28. Review.

PMID:
27741478
8.

Candidate gene studies of diabetic retinopathy in human.

Priščáková P, Minárik G, Repiská V.

Mol Biol Rep. 2016 Dec;43(12):1327-1345. Epub 2016 Oct 11. Review.

9.

Emerging role of chemokine CC motif ligand 4 related mechanisms in diabetes mellitus and cardiovascular disease: friends or foes?

Chang TT, Chen JW.

Cardiovasc Diabetol. 2016 Aug 24;15(1):117. doi: 10.1186/s12933-016-0439-9. Review.

10.

Effects of Long-Term Exercise Interventions on Glycaemic Control in Type 1 and Type 2 Diabetes: a Systematic Review.

Röhling M, Herder C, Roden M, Stemper T, Müssig K.

Exp Clin Endocrinol Diabetes. 2016 Sep;124(8):487-494. Epub 2016 Jul 20. Review.

PMID:
27437921
11.

[Cell engineering in the treatment of diabetes mellitus: current state and prospectives].

Nagibovich OA, Golota AS, Krassii AB.

Voen Med Zh. 2016 Apr;337(4):47-53. Review. Russian.

PMID:
27416722
12.

Dysregulation of glucose metabolism in preclinical type 1 diabetes.

Veijola R, Koskinen M, Helminen O, Hekkala A.

Pediatr Diabetes. 2016 Jul;17 Suppl 22:25-30. doi: 10.1111/pedi.12392. Review.

PMID:
27411433
13.

Continuous subcutaneous insulin infusion versus multiple daily injections of insulin for pregnant women with diabetes.

Farrar D, Tuffnell DJ, West J, West HM.

Cochrane Database Syst Rev. 2016 Jun 7;(6):CD005542. doi: 10.1002/14651858.CD005542.pub3. Review.

PMID:
27272351
14.

Incretin-based drugs for type 2 diabetes: Focus on East Asian perspectives.

Seino Y, Kuwata H, Yabe D.

J Diabetes Investig. 2016 Apr;7 Suppl 1:102-9. doi: 10.1111/jdi.12490. Epub 2016 Apr 18. Review.

15.

Discovery of gastric inhibitory polypeptide and its subsequent fate: Personal reflections.

Pederson RA, McIntosh CH.

J Diabetes Investig. 2016 Apr;7 Suppl 1:4-7. doi: 10.1111/jdi.12480. Epub 2016 Mar 14. Review.

16.

[GPR119 Receptor Agonists: Characteristics, Physiological Role, Prospects of Use in the Treatment of Diabetes Mellitus Type 2 and Metabolic Syndrome].

Tyurenkov IN, Kurkin DV, Bakulin DA, Lomkina EM, Volotova EV.

Usp Fiziol Nauk. 2015 Oct-Dec;46(4):28-37. Review. Russian.

PMID:
27183782
17.

Different role of zinc transporter 8 between type 1 diabetes mellitus and type 2 diabetes mellitus.

Yi B, Huang G, Zhou Z.

J Diabetes Investig. 2016 Jul;7(4):459-65. doi: 10.1111/jdi.12441. Epub 2016 Jan 9. Review.

18.

Evogliptin: a new dipeptidyl peptidase inhibitor for the treatment of type 2 diabetes.

Tan X, Hu J.

Expert Opin Pharmacother. 2016 Jun;17(9):1285-93. doi: 10.1080/14656566.2016.1183645. Epub 2016 May 13. Review.

PMID:
27156529
19.

Different intensities of glycaemic control for pregnant women with pre-existing diabetes.

Middleton P, Crowther CA, Simmonds L.

Cochrane Database Syst Rev. 2016 May 4;(5):CD008540. doi: 10.1002/14651858.CD008540.pub4. Review.

PMID:
27142841
20.

Maturity-Onset Diabetes of the Young (MODY): Making the Right Diagnosis to Optimize Treatment.

Amed S, Oram R.

Can J Diabetes. 2016 Oct;40(5):449-454. doi: 10.1016/j.jcjd.2016.03.002. Epub 2016 Apr 26. Review.

PMID:
27130141

Supplemental Content

Loading ...
Support Center